Pros and cons of aminoglutethimide for advanced postmenopausal breast cancer
- 1 December 1984
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 4 (4) , 289-295
- https://doi.org/10.1007/bf01806041
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Influence of acth on aminoglutethimide induced reduction of plasma steroids in postmenopausal breast cancerThe Journal of Steroid Biochemistry and Molecular Biology, 1984
- A Randomized Trial Comparing Surgical Adrenalectomy with Aminoglutethimide plus Hydrocortisone in Women with Advanced Breast CancerNew England Journal of Medicine, 1981
- A comparative trial of transsphenoidal hypophysectomy and estrogen suppression with aminoglutethimide in advanced breast cancerCancer, 1979
- Aminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*Journal of Clinical Endocrinology & Metabolism, 1978
- An abnormal luteal‐phase evening peak of plasma prolactin in women with a family history of breast cancerInternational Journal of Cancer, 1977
- Steroid abnormalities in endometrial and breast carcinoma: A unifying hypothesisJournal of Steroid Biochemistry, 1976
- Aromatization of Androgens by Human Abdominal and Breast Fat Tissue1Journal of Clinical Endocrinology & Metabolism, 1975
- Preliminary trial of aminoglutethimide in breast cancerCancer, 1973
- CONVERSION OF ANDROSTENEDIONE TO ESTRONE BY HUMAN FAT TISSUEJournal of Clinical Endocrinology & Metabolism, 1972
- Goiters with High Radioiodine Uptake and Other Characteristics of Iodine Deficiency in Rats Chronically Treated with Aminoglutethimide 1 , 2Endocrinology, 1970